For 2023, Ford has given the Escape Hybrid a styling makeover and equipped it with an updated infotainment system, which is sure to resonate with tech-focused buyers. But what the Escape Hybrid needed ...

It's been a banner year for anime as its popularity has grown exponentially and American animation looks towards the trailblazing Japanese form to reshape how it tells stories. But while series like ...

Health care spending in the US reached $4.9 trillion and increased 7.5 percent in 2023, growing from a rate of 4.6 percent in 2022. In 2023, the insured share of the population reached 92.5 percent, ...

In 2023, Transparency International worked as a united, global force for change. We have one vision: a world in which government, business, civil society and the daily lives of people are free of ...

AFBF’s Market Intel team has created a series highlighting agricultural losses incurred due to weather disasters and the disaster assistance programs meant to help mitigate their impacts. Previous ...

For many years, organizations have struggled to protect themselves from cyberattacks: companies, universities, and government agencies have expended enormous amounts of resources to secure themselves.

The season is over. A champion has been crowned. All that's left is to deliver a final, comprehensive ranking of every quarterback who started a game in 2023, judging them by the entire regular season ...

'Succession,' 'The Bear' and 'Beef' won the top awards for best drama series, best comedy series and best limited series, respectively. By Kimberly Nordyke Managing Editor, Digital Last Week Tonight ...

We've already rounded up the list of overall bestselling vehicles in the U.S. for 2023, and now we're diving deeper into the numbers to look more closely at an important segment of the market: ...

The U.S. labor market ended the year strong, creating more than 200,000 jobs in the last month of the year and nearly 2.7 million jobs in all of 2023, when seasonally adjusted. Consumer spending ...

Hot on the heels of the COVID-19 vaccine success story (including updated jabs that target Omicron subvariants of the rapidly shifting virus), 2023 saw the greenlighting of several new vital vaccines.